{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:22:19Z","timestamp":1770333739189,"version":"3.49.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>Hepatitis C virus infection remains one of the most critical healthcare issues worldwide, attracting attention for its high chronicity and extrahepatic impact. The continued development of direct antiviral antivirals (DAAs) has made hepatitis C virus infection curable. In recent years, it has been found that dysbiosis is often observed in chronic liver diseases, and chronic hepatitis C (CHC) is one of them. However, the role of intestinal flora and whether DAA has any effect on it remains unclear. In our review, we summarize the changes in intestinal flora before and after DAA treatment in different stages of CHC, as well as the research progress of probiotics in recent years, to provide new thinking for further research on the interrelationship between intestinal flora and CHC as well as for the clinical treatment of CHC.<\/jats:p>","DOI":"10.1097\/md.0000000000042301","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:10Z","timestamp":1754089270000},"page":"e42301","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intestinal flora of hepatitis C after direct antiviral drug therapy: A review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1274-903X","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0508-2123","authenticated-orcid":false,"given":"Ming Yu","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C.","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet (London)"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","article-title":"Breakthroughs in hepatitis C research: from discovery to cure.","volume":"19","author":"Manns","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jhep.2019.07.021","article-title":"Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.","volume":"71","author":"Rossi","year":"2019","journal-title":"J Hepatol"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome.","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0037-1602763","article-title":"The human gut microbiome in liver diseases.","volume":"37","author":"Davis","year":"2017","journal-title":"Semin Liver Dis"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases.","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut dysbiosis associated with hepatitis C virus infection.","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin Infectious Dis"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2011.06.063","article-title":"Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.","volume":"141","author":"Sandler","year":"2011","journal-title":"Gastroenterology"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"ofz255","DOI":"10.1093\/ofid\/ofz255","article-title":"Bacterial translocation and host immune activation in chronic hepatitis C infection.","volume":"6","author":"Moon","year":"2019","journal-title":"Open Forum Infectious Dis"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jfma.2022.08.022","article-title":"Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C.","volume":"122","author":"Huang","year":"2023","journal-title":"J Formosan Med Assoc"},{"key":"R12-20250918","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03009-0","article-title":"Changes in the gut microbiota after hepatitis C virus eradication.","volume":"11","author":"Honda","year":"2021","journal-title":"Sci Rep"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis.","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejim.2019.06.005","article-title":"Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients.","volume":"67","author":"P\u00e9rez-Matute","year":"2019","journal-title":"Eur J Internal Med"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiab094","article-title":"Improvement of gut diversity and composition after direct-acting antivirals in hepatitis C virus-infected patients with or without human immunodeficiency virus coinfection.","volume":"224","author":"Chuaypen","year":"2021","journal-title":"J Infect Dis"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/apt.14994","article-title":"Microbial translocation and T-cell activation are modified by direct-acting antiviral therapy in HCV-infected patients.","volume":"48","author":"Lattanzi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2016.07.005","article-title":"Gut microbiome and liver disease.","volume":"179","author":"Betrapally","year":"2017","journal-title":"Transl Res"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41598-022-09534-w","article-title":"Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents.","volume":"12","author":"Hsu","year":"2022","journal-title":"Sci Rep"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.31700","article-title":"Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis.","volume":"74","author":"Wellh\u00f6ner","year":"2021","journal-title":"Hepatology (Baltimore)"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1038\/s41598-023-41664-7","article-title":"The long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection.","volume":"13","author":"Chuaypen","year":"2023","journal-title":"Sci Rep"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C.","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathogens"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"e7521","DOI":"10.5812\/hepatmon.7521","article-title":"Probiotics as a novel treatment strategy against liver disease.","volume":"13","author":"Imani Fooladi","year":"2013","journal-title":"Hepatitis Monthly"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/nu10101457","article-title":"Gut microbiota\u2019s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics.","volume":"10","author":"Meng","year":"2018","journal-title":"Nutrients"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.3748\/wjg.v21.i41.11597","article-title":"Gut microbiota and host metabolism in liver cirrhosis.","volume":"21","author":"Usami","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dld.2010.10.015","article-title":"Gut microbiota and probiotics in chronic liver diseases.","volume":"43","author":"Cesaro","year":"2011","journal-title":"Digestive Liver Dis"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"781S","DOI":"10.1093\/jn\/137.3.781S","article-title":"Cross-talk between probiotic bacteria and the host immune system.","volume":"137","author":"Corth\u00e9sy","year":"2007","journal-title":"J Nutr"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"45176","DOI":"10.1038\/srep45176","article-title":"Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.","volume":"7","author":"Xue","year":"2017","journal-title":"Sci Rep"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"570851","DOI":"10.3389\/fmicb.2020.570851","article-title":"Lactobacillus acidophilus antimicrobial peptide is antagonistic to Aeromonas hydrophila.","volume":"11","author":"Akter","year":"2020","journal-title":"Front Microbiol"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2018.01318","article-title":"Preventive effect of a synbiotic combination of galacto and fructooligosaccharides mixture with Bifidobacterium breve M-16V in a model of multiple rotavirus infections.","volume":"9","author":"Rigo-Adrover","year":"2018","journal-title":"Front Immunol"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13099-022-00501-4","article-title":"The potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral loads.","volume":"14","author":"Ashour","year":"2022","journal-title":"Gut Pathogens"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12602-020-09663-6","article-title":"Hepatoprotective effect of probiotic lactic acid bacteria on thioacetamide-induced liver fibrosis in rats.","volume":"13","author":"Jantararussamee","year":"2021","journal-title":"Probiotics Antimicrob Proteins"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5897\/AJMR2018.9028","article-title":"Lactobacillus acidophilus and Bifidobacteria spp. Having antibacterial and antiviral effects on chronic HCV infection.","volume":"13","author":"Allam","year":"2019","journal-title":"Afr J Microbiol Res"},{"key":"R33-20250918","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut\u2013liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature.","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R34-20250918","first-page":"9726786","article-title":"Advances in gut microbiota of viral hepatitis cirrhosis.","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A universal gut-microbiome-derived signature predicts cirrhosis.","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab"},{"key":"R36-20250918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/liv.15041","article-title":"Bile acid dysmetabolism in the gut\u2013microbiota\u2013liver axis under hepatitis C virus infection.","volume":"42","author":"Inoue","year":"2022","journal-title":"Liver Int"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"567654","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD.","volume":"11","author":"Dai","year":"2020","journal-title":"Front Microbiol"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection.","volume":"11","author":"Preveden","year":"2017","journal-title":"Exp Rev Gastroenterol Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:00:31Z","timestamp":1758232831000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":38,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042301","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}